LC-MS/MS-based approach for obtaining exposure estimates of metabolites in early clinical trials using radioactive metabolites as reference standards.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Drug Metabolism Letters

• Publication date

  2007-11-30

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.2174/187231207783221411PMID 19356058
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• A radioactivity-mass spectrometry calibration method coupled with biosynthesis to generate a metabolite standard for enzyme kinetics studies.

  2024cites this paper
• A MIST conception: what has been learned from twenty years of human metabolite safety assessment?

  2023cites this paper
• Biosynthesis using cytochrome P450 enzymes: Focus on synthesis of drug metabolites.

  2022cites this paper
• Bifunctionalized isotopologues as calibrants for standard-free quantitation of drug metabolites in plasma by liquid chromatography coupled with radiometry and mass spectrometry.

  2021cites this paper
• Biotransformation and bioactivation reactions – 2018 literature highlights

  2019cites this paper
• Standard-Free Bioanalytical Approach for Absolute Quantitation of Drug Metabolites Utilizing Biosynthesis of Reciprocal Radio and Stable Isotopologues and Its Application.

  2017cites this paper
• Microdosing, isotopic labeling, radiotracers and metabolomics: relevance in drug discovery, development and safety.

  2017cites this paper
• METABOLITE TECHNOLOGY: QUALITATIVE AND QUANTITATIVE

  2016cites this paper
• “MIST” AND OTHER METABOLITE GUIDELINES IN THE CONTEXT OF INDUSTRIAL DRUG METABOLISM

  2016cites this paper
• Absolute quantification of imipramine and its metabolites in vivo utilizing calibrators from radiolabeled in vitro incubations.

  2016cites this paper
• Regulatory Submission: MIST and Drug Safety Assessment

  2015cites this paper
• Reflecting on a decade of metabolite screening and monitoring.

  2014cites this paper
• Data-driven approach for cross-species comparative metabolite exposure assessment: how to establish fundamental bioanalytical parameters for the peak area ratio method.

  2014cites this paper
• Role of Metabolism in Drug Development

  2014cites this paper
• The science of laboratory and project management in regulated bioanalysis.

  2014cites this paper
• UHPLC-ESI-HRMS Quantitation of Metabolites without Using Reference Standards: Impact of LC Flow Rate and Mobile Phase Composition on MS Responses

  2013cites this paper
• Metabolites in Safety Testing

  2013cites this paper
• Increased function of pronociceptive TRPV1 at the level of the joint in a rat model of osteoarthritis pain

  2013cites this paper
• Activity-based exposure comparisons among humans and nonclinical safety testing species in an extensively metabolized drug candidate

  2013influential citation
• Radiolabeled mass-balance excretion and metabolism studies in laboratory animals: a commentary on why they are still necessary

  2013cites this paper
• The early estimation of circulating drug metabolites in humans

  2012cites this paper
• Integrated quantitative and qualitative workflow for in vivo bioanalytical support in drug discovery using hybrid Q-TOF-MS.

  2012cites this paper
• Radiolabelled mass-balance excretion and metabolism studies in laboratory animals: are they still necessary?

  2012cites this paper
• Use of radiolabeled compounds in drug metabolism and pharmacokinetic studies.

  2012cites this paper
• Mass spectrometric tools for cell and tissue studies.

  2012cites this paper
• Analytical Method Development and Validation in Accordance to the Regulatory Guidelines

  2012cites this paper
• Hybrid Mass Analyzers in Drug Metabolism Applications

  2012cites this paper
• Analysis of polar metabolites by hydrophilic interaction chromatography--MS/MS.

  2011cites this paper
• Plasma Stability-Dependent Circulation of Acyl Glucuronide Metabolites in Humans: How Circulating Metabolite Profiles of Muraglitazar and Peliglitazar Can Lead to Misleading Risk Assessment

  2011cites this paper
• From definition to implementation: a cross-industry perspective of past, current and future MIST strategies

  2011cites this paper
• Evaluation of relative LC/MS response of metabolites to parent drug in LC/nanospray ionization mass spectrometry: potential implications in MIST assessment.

  2011cites this paper
• A Simple Liquid Chromatography-Tandem Mass Spectrometry Method to Determine Relative Plasma Exposures of Drug Metabolites across Species for Metabolite Safety Assessments

  2010cites this paper
• Metabolites in Safety Testing: “MIST” for the Clinical Pharmacologist

  2010cites this paper
• Novel MS solutions inspired by MIST.

  2010cites this paper
• Integrated strategies for assessment of metabolite exposure in humans during drug development: analytical challenges and clinical development considerations.

  2009cites this paper
• Meeting Report Meeting Report: Metabolites in Safety Testing (mist) Symposium—safety Assessment of Human Metabolites: What's Really Necessary to Ascertain Exposure Coverage in Safety Tests?

  year unknowncites this paper